Centre de médecine du sommeil- Clinique André Renard
Herstal, Liège, 4040, Belgium
NCT Number: NCT06092710
the study aims to evaluate the accuracy correlation between subjective perception of the air flow through airways from patients and survey and/or polysomnography they spent, using a brief clinical protocol they answered with a manual therapist
Looking for future studies?
Notify Me18 year–77 year
All sexes
Observational
Herstal, Liège, 4040, Belgium
The subjects in the study are 18 to 77 years old and present the following conditions:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment with antipsychotics, anxiolytics, soporifics or muscle relaxants started within the two months preceding the study.
Treatment with intraoral implants during the study or in the two months preceding the study
verbal and manual guidance of subjects from a therapist to experiment the subjective perception of the air flow through their airways and airways collapsibility
Other names: subjective perception scale of the air flow through airways, subjective perception of the air flow protocol, protocol of subjective perception of airways collapsibility, subjective perception scale of airways collapsibility
Time frame: during the clinical protocol, about 15 to 20 minutes
In this study, we set out to create a scale of subjective perception of airflow. Assessment of subjects' perception of airflow using different positions or maneuvers: responses are scored for perceived ease of airflow.
Items will be assigned "0" if they feel no expected change in airflow due to the maneuver up to "+1" if they feel a variation corresponding to the maneuver. Summed together, they define a score by item category (ST):
Time frame: during the examination and the OSASSS protocol (15 to 20 min)
In this study, we set out to create a scale, so we can only describe what we did.
score by item category (ST):
Time frame: during the examination protocol, about 15 to 20 minutes
Objective: to determine an intermediate final score (IFS) and total final score (TFS) threshold for classifying the severity of OSA in at-risk subjects. The questionnaire comprises 18 questions relating to upper airway collapsibility. Each item concerns the aggravating or facilitating factors perceived by the patient or therapist during the clinical maneuvers used to obtain the IFS. To obtain the TFS, we add items concerning factors known to be unfavorable to upper airway patency (snoring, mouth ventilation, tonsils, dento-skeletal class, etc.), as well as two questionnaires used in the sleep laboratory at the André Renard Clinic (Epworth sleepiness scale and FFF questionnaire). IFS: min=0/max=13. TFS: min= 0/max=26. The higher the score, the greater the risk of OSA. Clinically, the scale is designed to perform the IFS, giving a score out of 13. Then, if the score is above the first cut-off point, the questionnaire is completed to establish the TFS out of 26.
Center for Sleep Medicine - Clinique André Renard
Other
Predictive Value of OSA Based on the Evaluation of the Subjective Feeling of the Air Flow Through Airways, a Randomized Controlled Study
Acronym: OSASSS1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05094271
Alzheimer Disease, Apnea
La Jolla, California, United States
View Trial DetailsNCT04950894
Apnea, Apnea+Hypopnea
Birmingham, Alabama, United States
View Trial DetailsNCT04875364
Apnea, Dyssomnias
La Jolla, California, United States
View Trial DetailsNCT06540716
Apnea, Dyssomnias
Singapore
View Trial Details